Aspiring to Excellence – programme 2020 open for applications
Following a successful start for the first cohort, applications are now open for the Aspiring to Excellence programme in 2020. The programme is designed to encourage and recognise service improvement in axial SpA (AS) care and is a strategic partnership between NASS, BRITSpA and sponsoring companies AbbVie, Biogen, Novartis and UCB. Whilst COVID19 is impacting…
Dedicated COVID-19 page for Osteopaths
In light of the current COVID-19 situation, the Institute of Osteopathy is providing information for all osteopaths, based on the most current UK Government advice. The current situation is unprecedented, the advice is changing rapidly and in some cases, there may not yet be definitive answers available. However, the iO will endeavour to support our…
Free CPD Webinar from BASRaT
Free CPD Webinar: Virtual Consultations with Mike James Wednesday 1 April, 19:00 Join BASRaT live on Zoom to discuss all things virtual! The discussion will focus on the clinical considerations when conducting a virtual consult, including how to adapt assessments and rehab with the lack of face-to-face contact. Mike will also share his thoughts on…
NRAS: Coronavirus and RA
Many people with rheumatoid arthritis (RA) and their families will be concerned about how the Coronavirus (COVID-19) affects them. NRAS has provided a summary of all the important information that you need to know about Coronavirus and rheumatoid arthritis, including: What is Coronavirus (COVID-19)? Frequently Asked Questions Links to official information NRAS Live: Ask your…
COVID-19 / Coronavirus updates for Axial SpA patients
NASS is regularly updating their website with relevant COVID-19 information including how patients can assess their risk, medicines and biologic therapy, mental health and the effect of the virus on work and benefits. www.nass.co.uk/covid19 Aspiring to Excellence programme 2020 open for applications Following a successful start for the first cohort, applications are now open for…
NICE resources versus Covid-19
NICE has produced new, rapid guidelines on the active management of COVID-19 infection, which are likely to include patients with rheumatoid arthritis. NICE is also reviewing guidance on ibuprofen and other non-steroidal anti-inflammatory drugs in relation to impact on Covid-19 illness. Please see this page: https://www.nice.org.uk/covid-19
COVID-19 Information for people with MSK
[Editor’s note: this post was published in March 2020 and has not been updated since. For more up-to-date reading, please refer to this COVID-19 Information page, which has been updated as new data and resources have come to light.] Many NHS staff who would normally answer calls from patients are redeployed to the fight against…
COVID-19 / Coronavirus info
Last updated 8/11/22 [toc] This page lists the most relevant information we can find on COVID-19 relevant to people with MSK conditions. We update this page as new information becomes available. It includes information for professionals, patients, parents and guidance for Wales and Scotland. Six key resources for MSK. Key resources Latest advice for England….
Right on Time campaign
Versus Arthritis is campaigning to ensure that everyone who needs a joint replacement gets timely access to treatment. Hundreds of thousands of joint replacement operations take place each year. More than 90% of people who have hip and knee replacements have osteoarthritis. At the end of February, Versus Arthritis released figures revealing that, in one…
NRAS accessing advanced therapies
Accessing Advanced Therapies (biologics, biosimilars, oral JAK inhibitors) For some time, NRAS has been concerned that some Clinical Commissioning Groups (CCGs) have been artificially restricting access to advanced therapies (biologics, biosimilars/JAK inhibitors) and undertook a Freedom of Information request to all CCGs about this. Following discussions with NHS England on behalf of RA patients about…